The effect of growth hormone on biochemical parameters of bone turnover, and age-standardized IGF-I and IGFBP-3 in adult hypopituitarism: A randomized crossover trial

Endocrinology and Metabolism, Supplement

Volumn 4, Issue 2, 1997, Pages 129-134

  Florkowski, C M ^a   Walmsley, T A ^a   George, P M ^a   Livesey, J H ^a   Espiner, E A ^a   Donald, R A ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; FEMALE; HUMAN; HYPOPITUITARISM; MALE; OSTEOLYSIS; OSTEOSYNTHESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030775714     PISSN: 1074939X     EISSN: 20935978     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Sonksen PH, Cuneo RC, Salomon F, McGauley G, Wiles CM, Wilmshurst P, Byrne C, Hesp R, Lowy C, Weissberger A. Growth hormone therapy in adults with growth hormone deficiency. Acta. Paediatr. Scand. (Suppl.) 1991; 379: 139-146.
2. Mardh G, Lundin K, Borg G, Jonsson B, Lindeberg A on behalf of the investigators. Growth hormone replacement in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-con-trolled clinical; trials. Endocrinol. Metab. 1994; 1(Suppl. A): 43-49.
3. Balducci R, Toscano V, Pasquino AM, Mangiantini A, Municchi G, Armenise P, Terracina S, Prossomariti G, Boscherini B. Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy. Eur. J. Endocrinol. 1995; 132: 42-46.
4. Wollmann HA, Schonau E, Blum WF, Meyer F, Kruse K, Ranke B. Dose-dependent responses in insulin-like growth factors, insulin-like growth factor binding protein-3 and parameters of bone metabolism to growth hormone therapy in young adults with growth hormone deficiency. Horm. Res. 1995; 43(6): 249-56.
5. Rasat R, Livesey JL, Espiner EA, Abbott GD, Donald RA. IGF-I and IGFBP-3 screening for disorders of Growth Hormone Secretion. NZ Med. J. 1996; 109: 156-159.
6. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini Marciano-Mone C, Sacca L, Bellastella A. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH therapy at low doses. J. Clin. Endocrinol. Metab. 1993; 77: 1671-6.
7. O Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J. Clin. Endocrinol. Metab. 1993; 76: 1344-8.
8. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J. Clin. Endocrinol. Metab. 1994; 78: 669-674.
9. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Lindstedt G, Bengtsson B-A. Increased fracture rate in growth hormone (GH) deficient adults. 77th Annual Meeting US Endocrine Soc, Washington DC 1995; (P2- 251).
10. Schlemmer A, Johansen JS, Pedersen SA, Jorgensen JOL, Hassager C, Christiansen C. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin. Endocrinol. 1991; 35: 471-476.
11. Sartorio A, Conti A, Guzzaloni G, Faglia G. Growth hormone treatment in adults with growth hormone deficiency: effects on new biochemical markers of bone and collagen turnover. J. Endocrinol. Invest. 1993; 16: 893-898.
12. Vandeweghe M, Taelman P, Kaufman J-M. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone deficient males. Clin. Endocrinol. 1993; 39: 409-15.
13. Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clin. Endocrinol. 1995; 42: 249-254.
14. Rosen T, Johannsson G, Hallgren P, Caidahl K, Bosaeus I, Bengtsson B-A. Beneficial effects of 12 month replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinol. Metab. 1994; 1: 55-66.
15. Degerblad M, Elgindy N, Hall K, Sjoberg H-E, Thoren M. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta. Endocrinol. 1992; 126: 387-93.
16. Kann P, Piepkorn B, Schehler B, et al. Replacement therapy with recombinant human growth hormone (GH) in GH-deficient adults: effects on bone metabolism and bone mineral density in a 2-year prospective study. Endocrinol. Metabol. 1995; 2 (Suppl. B): 103-110.
17. Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM. Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clin. Endocrinol. 1995; 42: 627-633.
18. Zender R. Analyse de l'Hydroxyproline Urinaire. Methode et Valeurs Frequentes. Clin. Chim. Acta. 1972; 37: 263-269.
19. Pybus J, Fieldman FJ, Bambers GN. Measurement of total calcium in serum by atomic absorption spectroscopy with use of a strontium internal reference. Clin Chem 1970; 16: 995-1007.
20. Breier BH, Milsom SR, Blum WF, Schwander J, Gallaher BW, Gluckman PD. Insulin-like growth factors and their binding proteins in plasma and milk after growth hormone-stimulated galactopoiesis in normally lactating women. Acta. Endocrinol. 1993; 129: 427-435.
21. Lamberts SWJ, Valk NK, Binnerts A. The use of growth hormone in adults: a changing scene. Clin. Endocrinol. 1992; 37: 111-115.
22. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A. A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodelling in normal human volunteers. J. Bone. Min. Res. 1990; 5: 609-618.
23. Mochizuki H, Hakeda Y, Wakatusi N, Usui N, Akashi S, Sato T, Tanaka K, Kumegawa M. Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 1992; 131: 1075-1080.
24. Hill PA, Reynolds JJ, Meikle MC. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology 1995; 136: 124-131.
25. Slootweg MC, Most WW, van Beek E, Schot LPC, Papapoulos SE, Lowik CWGM. Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I. J. Endocrinol. 1992; 132: 433-438.
26. Florkowski CM, Holdaway IM, Manning PJ, Donald RA. The case for growth hormone replacement in adult hypopituitarism. NZ Med. J. 1996; 109: 349-351.